Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control

SiPore21® Silica “Molecular Sieves” Offer a Promising Non-Pharmaceutical Alternative SHINE Trial Marks a Milestone in Prediabetes and Weight Control Research STOCKHOLM, Oct. 9, 2023 /PRNewswire/ — Sigrid Therapeutics announces the commencement of the SHINE clinical trial for SiPore21® –…